Spontaneous rupture of spleen during peripheral blood stem cell mobilization in a patient with breast cancer

Haematologica

Volumn 85, Issue 5, 2000, Pages 559-560

  Pitini, Vincenzo ^a,b   Ciccolo, Antonio ^a   Arrigo, Carmela ^a   Aloi, Giuseppa ^a   Micali, Carmelo ^a   La Torre, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cyclophosphamide (CTX); Peripheral blood stem cell (PBSC); Recombinant human (rh) G CSF

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MYELOPOIESIS; PERIPHERAL BLOOD STEM CELL; SPLEEN RUPTURE; SPLENOMEGALY;

ADULT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; RUPTURE, SPONTANEOUS; SPLENIC DISEASES;

EID: 0033918520     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Gianni AM, Siena S, Bregni M, et al. Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. J Clin Oncol 1997;15:23112-21.
2. Frampton JE, Lee CR, Faulds D. Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia. Drugs 1994; 48:731-60.
3. Becker PS, Wagle TM, Matous S, et al. Spontaneous splenic rupture following administration of granulocyte colony-stimulating factor (G-CSF): occurrence in an allogeneic donor of peripheral blood stem cells. Biol Blood Marrow Transplant 1997; 3:45-9.
4. Falzetti F, Aversa F, Minelli O, Tabilio A. Spontaneous rupture of spleen during peripheral blood stem-cell mobilisation in a healthy donor. Lancet 1999; 353: 555.
5. Dale DC, Bonilla MA, Davis MW, et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81: 2496-502.
6. Siena S. Towards the integration of hematopoietic stem cells into therapy of breast cancer? Haematologica 1999; 84:865-7.